Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Early Diagnosis and Warning Role of Erectile Dysfunction

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2008 by Sun Yat-sen University
Sponsor:
Collaborator:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Information provided by:
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01249703
First received: November 29, 2010
Last updated: NA
Last verified: January 2008
History: No changes posted

November 29, 2010
November 29, 2010
January 2008
October 2010   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Early Diagnosis and Warning Role of Erectile Dysfunction
The Early Diagnosis and Warning Role of Erectile Dysfunction:a Multi-institutional Clinical Study.
  1. Find the early diagnostic markers of erectile dysfunction;
  2. Study the warning role of ED in some diseases.
Not Provided
Observational
Observational Model: Case Control
Not Provided
Not Provided
Probability Sample

men with erectile dysfunction healthy men general male population

  • Erectile Dysfunction
  • Endothelial Dysfunction
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
150000
January 2020
October 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Male and at least 18 years of age.
  2. Provide signed informed consent.
  3. Have a history of erectile dysfunction (ED: defined as a consistent change in the quality of erection that adversely affects the subject's satisfaction with sexual intercourse) .
  4. Have a stable monogamous relationship with a female partner. To some subjects with poor sexual experience, re-evaluation would be conducted after a 4-weeks sex education.
  5. Make at least four sexual intercourse attempts with the female sexual study partner during the 4-week therapeutic period without medication.
  6. Agree not to use any other ED treatment for at least 4 weeks.

Exclusion Criteria:

  1. severe diseases (such as congestive heart failure, arrhythmia, significant renal or hepatic dysfunction and anemia);
  2. Had clinically noteworthy penile deformities, pelvic surgery or trauma of perineal region;
  3. Had received long-term pharmacotherapy (including antioxidant agents, vitamins and traditional Chinese drugs).
  4. An addiction problem (with a history of injection or administration of opium, poppy, heroin, hemp, morphine, cocaine, caffeine, ketamine and meperidine etc.)
Male
18 Years to 80 Years
Yes
Contact: Chunhua Deng, MD, PhD (01186)20-87333300 dch0313@163.com
Contact: Yanping Huang, MD (01186)20-87333300 hyppin@gmail.com
China
 
NCT01249703
Chunhua Deng
Yes
Chunhua Deng, Department of Urology
Sun Yat-sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Principal Investigator: Chunhua Deng, MD, PhD Department of Urology
Sun Yat-sen University
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP